Related Experiment Video
Updated: Jul 15, 2026
07:45
A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
Published on: November 8, 2014
Zebrafish: an emerging model system for human disease and drug discovery
1Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Clinical Pharmacology and Therapeutics
|May 15, 2007
Summary
Zebrafish embryos offer a powerful vertebrate model for drug discovery and toxicity studies. Their genetic accessibility and rapid development make them a valuable alternative to traditional animal models in research.
Area of Science:
- Pharmacology and Toxicology
- Developmental Biology
- Genetics
Background:
- Mammalian models like mice are standard in drug development but have limitations.
- There is a need for complementary vertebrate model systems.
- Zebrafish (Danio rerio) are emerging as a promising alternative.
Purpose of the Study:
- To review the utility of zebrafish embryos in drug discovery and toxicity assessment.
- To summarize the establishment of zebrafish disease models, particularly for neoplasia.
- To highlight zebrafish as a viable model for in vivo studies.
Main Methods:
- Review of recent research on drug discovery and toxicity in zebrafish embryos.
- Synopsis of efforts to create disease models in zebrafish, focusing on neoplasia.
- Utilizing zebrafish's genetic tractability and rapid development.
Main Results:
- Zebrafish embryos are permeable to drugs and amenable to genetic manipulation.
- Recent studies demonstrate zebrafish's potential in drug discovery and toxicity screening.
- Progress has been made in establishing zebrafish models for diseases like cancer.
Conclusions:
- Zebrafish embryos are a facile vertebrate model for studying human disease and drug responses.
- They offer medium to high throughput capabilities, complementing existing animal models.
- Zebrafish represent a valuable tool for advancing drug development and toxicological research.
